Cahaba Research

Birmingham, Alabama 35242

0 studies enrolling now · 8 studies all time

What they study most

COVID-19, Influenza -Like Illness, Influenza A, Influenza B, Irritable Bowel Syndrome Characterized by Constipation, Low Back Pain, Obesity, Overweight, T2D, Type 2 Diabetes

Studies at this site

• A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN) — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities — Completed
• A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) — Completed
• Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use — Completed
• A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes — Completed
• Norketotifen for the Treatment of Uncomplicated Influenza-like Illness — Completed
• A Phase 3 Study of Tanezumab for Chronic Low Back Pain — Completed
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) — Completed